Levocetirizine Dihydrochloride Tablet
Product Images NDC 50228-136

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 50228-136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (400 mg (500 Tablets Bottle))

This is a description of Levocetirizine Dihydrochloride Tablets. Each film-coated tablet contains 5 mg of the active ingredient, evocetirizine dinyarochlorice, USP. The tablets should be stored at 20-25°C (63-77°F) with excursions permitted up to 15-30% (59-86°F) and dispensed in a tight, light-resistant container with a child-resistant closure. The recommended dosage should be followed as per the package. The tablets are for oral administration and are manufactured by SoeGen Pramaceticas in Heuppauge, NY 11768. Rev: 07/16 is printed on the label.*

FDA Label Image

Package Label-principal Display Panel (100 mg (30 Tablets Bottle))

This is a medication called Exch Fim, which is a coated tablet containing Levocetirizine hydrochloride, at a strength of 5mg. The tablets are meant to be dispensed in light-resistant containers to protect their efficacy. The package insert contains complete dosage recommendations and the medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted from 10°C to 30°C (59°F to 86°F). This medication is meant for oral administration and comes in a pack of 30 tablets, and is only available by prescription. It is manufactured by ScieGen Pharmaceuticals located in Hauppauge, NY.*

FDA Label Image

Levocetirizine 5mg 90ct

This is a description of Levocetirizine Dihydrochloride Tablets, USP which is sold in a package containing 90 coated tablets. The tablets are meant for oral consumption and must be stored in a tightly sealed container away from children, at a controlled room temperature. The complete dosage details are mentioned in the package insert provided. The medicine is manufactured by ScieGen Pharmaceuticals in Hauppauge, NY, and requires a prescription for dispensing.*

FDA Label Image

Chemical Structure (Levocetirizine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.